Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
Clinical trial NCT06151730 · RECRUITING
Trial details
- NCT number
- NCT06151730
- Sponsor
- Mayo Clinic
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-01-05
- Primary completion
- 2026-06-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.